1Q20 vs 1Q19:
1Q20 vs 4Q19：
James Ng Stock Pick Performance:
Since Recommended Return:
a) FRONTKN (FRONTKEN CORP BHD), recommended on 12 Aug 18, initial price was RM0.715, rose to RM3.32 (dividend RM0.04) in 1 year 11 months 3 days, total return is 369.9%
b) TOPGLOV (TOP GLOVE CORP BHD), recommended on 1 July 18, initial price was RM12.14, rose to RM43.60 (adjusted)(dividend RM0.52) in 2 Years 14 days, total return is 263.4%
c) MI (MI TECHNOVATION BERHAD), recommended on 2 Jun 19, initial price was RM1.67, rose to RM5.01 (adjusted)(dividend RM0.055) in 1 Year 1 month 13 days, total return is 203.3%
d) OPENSYS (OPENSYS M BHD), recommended on 24 May 20, initial price was RM0.355, rose to RM0.765 in 1 month 21 days, total return is 115.5%
e) KKB (KKB ENGINEERING BHD), recommended on 1 Jul 18, initial price was RM0.795, rose to RM1.65 (dividend RM0.04) in 2 Years 14 days, total return is 112.6%
f) JAKS (JAKS RESOURCES BHD), recommended on 20 Jan 19, initial price was RM0.575, rose to RM0.875 in 1 year 5 months 24 days, total return is 52.2%
g) PWROOT (POWER ROOT BHD), recommended on 7 Oct 18, initial price was RM1.59, rose to RM2.18 (dividend RM0.188) in 1 Year 9 months 8 days, total return is 48.9%
我为想从马来西亚股票市场赚钱的读者提供STOCK PICK服务。想订阅我的邮件以从股票市场获取良好回报的人，可以通过jamesngshare@gmail.com 或我的FB页面与我联系。
Whatsapp : 011 - 15852043
Facebook Group: https://www.facebook.com/groups/jamesinvesting
这个是我的TELEGRAM Group链接，大家可以在这个Group获知何时做Fb live: https://t.me/joinchat/LhwHNhdU1fDgxrSafTrTiw
[PHARMANIAGA BHD: stronger demand from the Indonesia Division]
1Q20 vs 1Q19:
For the first quarter ended 31 March 2020, the Group delivered an improved revenue of RM820 million, up by 4.3% compared with RM786 million in the previous year’s corresponding quarter. This was primarily due to stronger demand from the Indonesia Division. The Group registered a profit before zakat and taxation (PBT) of RM31 million, reflecting a growth of 2.1% compared with last year’s corresponding quarter.
Accordingly, profit after tax (PAT) for the quarter under review grew by 14.1% to RM22 million, compared with RM20 million in the same quarter last year. The Logistics and Distribution Division turned in a higher PBT of RM23 million, up by 82.9% compared with RM13 million in the same quarter last year, driven by stronger contributions from Government hospitals as well as lower operating costs.
The Manufacturing Division posted a PBT of RM9 million on the back of a revenue of RM68 million, in line with order trends from Government hospitals. The Division continues to hold positive prospects, propelled by launches of new products and ongoing international expansion, coupled with increased capacity utilisation via its contract manufacturing business. The Indonesia Division recorded a deficit of RM0.03 million.
1Q20 vs 4Q19:
In comparison with the immediate preceding quarter, the Group’s revenue increased significantly to RM820 million for the first quarter. This was primarily attributable to stronger demand from Government and private hospitals in Malaysia and Indonesia. This saw the Group post a PBT of RM31 million compared with a deficit of RM238 million in the immediate preceding quarter. Accordingly, PAT for the quarter under review increased to RM22 million, compared with a deficit of RM179 million in the immediate preceding quarter.
The Group was able to deliver solid results in the first quarter of the year. As the healthcare sector does its utmost to prevent the further spread of this virus, the various economic stimulus packages and Covid-19 related initiatives announced by the Government will help to address the needs of healthcare practitioners, providing much-needed funds and support.
As a leading pharmaceutical manufacturer, Pharmaniaga is conscious of its role during this critical time. The Group is dedicated to fulfilling its contract with the Ministry of Health (MOH) for the provision of medicines and medical supplies to MOH facilities, as well as logistics and distribution services to MOH. In tandem with this, to ensure sustainable growth, the Group continues to enhance manufacturing and operational efficiencies and expand its research and development capabilities to explore new avenues to grow its business, including for its Indonesian operations.
I wish to share my strategy to readers, hope that they can perform well after reading this. I am using Fundamental Analysis:
the forecasted growth of a company must > 14% per year
I wish to convince readers to learn FA in order to make money from stock market.
I am providing STOCK PICK SERVICE for readers who want to make money from Malaysian stock market. Those who want to subscribe to my mailing list to achieve a good return from stock market, you can contact me at firstname.lastname@example.org or PM me in my FB page.
This sharing is purely a discussion and analysis of the sector, buying or selling at your own risk. Please Like and Share this post. Final decision is always yours, thank you.